Description
PT-141 peptide, also known as Bremelanotide, is a synthetic melanocortin receptor agonist widely studied for its potential role in sexual function research, neuroendocrine signaling, and central nervous system activity. Unlike compounds that primarily target vascular pathways, PT-141 acts by activating melanocortin receptors in the brain, making PT-141 peptide research an important area of investigation within neuroscience and sexual health research. Its unique mechanism of action has attracted significant scientific interest for its influence on neurological pathways involved in desire, arousal, and hormonal regulation.
Current PT-141 research has explored the interaction of PT-141 peptide with melanocortin receptors, particularly MC3R and MC4R, which are involved in regulating sexual behavior, energy homeostasis, and neuroendocrine function. Numerous PT-141 studies continue to investigate its biological activity, receptor selectivity, and potential effects on central nervous system signaling, neurotransmitter modulation, and physiological responses associated with sexual function. Researchers are also examining PT-141 for its broader applications in neurobiology and peptide science to better understand its pharmacological profile and mechanisms of action.
As interest in melanocortin receptor research continues to expand, PT-141 peptide remains an important investigational compound across multiple areas of biomedical research. Ongoing preclinical and clinical studies continue to improve the scientific understanding of PT-141, its receptor interactions, and its potential role in advancing neuroscience and endocrine research.
PT-141 (Bremelanotide) is intended for laboratory and scientific research purposes only. This investigational research peptide is not approved for human consumption or therapeutic use.





Reviews
There are no reviews yet.